AHA Comments to FDA Re: Blood Glucose Monitoring Test Systems

AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.

View the following letter for details. 

Related Resources

Advisory
Member
The AHA released new tools to help the field prepare for appropriate use criteria reporting requirements that will start to go into effect on a voluntary basis…
Infographics
Public
The Protecting Access to Medicare Act (PAMA) requires the Centers for Medicare & Medicaid Services (CMS) to establish a program that promotes A
Infographics
Public
The Protecting Access to Medicare Act (PAMA) requires the Centers for Medicare…
Letter
Public
Hospitals and health systems understand the importance of making health care more affordable for everyone and they “have been tackling the issue head on,…
Press Releases
Case Studies
Public
Montefiore Health System uses the Collaborative Care Model to better serve patients with significant medical and mental health conditions and socioeconomic…